Business

Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025

Continued revenue growth and commercial projects fuel Telescope's successful intelligent automation and advanced chemical manufacturing portfolioVancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, reports financial results for the fiscal year ended August 31, 2025. The...

articleTelescope Innovations CorpDecember 23, 20253/company/telescope-innovations-corp/news/telescope-innovations-reports-significant-milestones-010000828
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025

About this update from Telescope Innovations Corp

[{"type":"text","content":"Continued revenue growth and commercial projects fuel Telescope's successful intelligent automation and advanced chemical manufacturing portfolio","length":149,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) -  Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, reports financial results for the fiscal year ended August 31, 2025. The Company generated revenues of $5.8 million during this period, with an Adjusted EBITDA loss of $402K (Figure 1). Telescope continues to strategically reinvest revenues to enhance R&D and commercialization capacity, with significant accomplishments as a result.","length":658,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":712,"url":"https://media.zenfs.com/en/newsfile_64/291022af76aac16de13b9d0aa6027c57"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TH6aej1rgp.pSzs2oWXhgA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEyNDM7Y2Y9d2VicA--/https://media.zenfs.com/en/newsfile_64/291022af76aac16de13b9d0aa6027c57","width":550,"height":712}},"href":"https://images.newsfilecorp.com/files/8923/278958_90c80b1fc4203bda_001full.jpg","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Figure 1. Revenue and EBITDA for FY 23, 24, and 25 in CAD, along with major milestones achieved in each fiscal year.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8923/278958_90c80b1fc4203bda_001full.jpg","length":255,"tagName":"p","attribs":{}},{"type":"text","content":"OPERATIONAL HIGHLIGHTS","length":22,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Continued delivery of technical milestones for multi-year, funded project with Pfizer for Self-Driving Lab ("SDL") development","length":136,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"New commercialization opportunities for SDLs in Asia, leading to Telescope's deployment of the first SDL for pharmaceutical development in Korea in FY 26","...

More updates from Telescope Innovations Corp

TelescopeThe Companyintelligent automationNewsfile Corp.lithium sulfideSDLsales performance